Executive Summary
The June 8, 2026, filing batch reveals a market bifurcated between aggressive capital markets activity and significant corporate distress. A wave of debt and equity financing dominates, with $3.3 billion in new debt offerings from ATI, Hubbell, and FS KKR Capital Corp, alongside a $400 million convertible note from Celcuity, signaling robust credit appetite for investment-grade and BDC names.
However, this is counterbalanced by three high-profile bankruptcies (GoHealth, Silver Star Properties, and a reverse merger from SUNation Energy), indicating severe stress in healthcare, real estate, and solar manufacturing. Governance upheaval is a key theme, with a CEO fired for misconduct at Perrigo, three directors removed at Pangaea Logistics, and a wave of director/officer resignations across multiple Invesco ETFs. The most transformative event is Nurix Therapeutics' $700 million upfront collaboration with Roche, a landmark biotech deal that dwarfs all other transactions in this batch. Insider activity is notably absent, but the lack of insider buying alongside the equity offerings suggests cautious management sentiment. The data points to a 'haves vs. have-nots' environment where well-capitalized firms are raising cheap debt for M&A, while over-levered entities are forced into restructuring.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from June 05, 2026.
Investment Signals (12)
- Nurix Therapeutics (NRIX) (BULLISH)▲
Landmark $700M upfront + $2.3B milestones from Roche for BTK degrader bexobrutideg; 40/60 cost share with 50/50 US profit split. This is a transformative, non-dilutive capital infusion that validates the platform and provides a multi-year cash runway.
- Ares Capital (ARCC) (BULLISH)▲
Established a $1B commercial paper program backstopped by a $5.5B revolver, reducing funding costs for the largest BDC. This is a capital allocation efficiency move that should improve NIM and ROE.
- Hubbell (HUBB) (BULLISH)▲
Priced $1.9B in three tranches (4.65%-5.15%) to fund the NSI Electrical acquisition. The ability to lock in long-term debt at these rates for a strategic acquisition signals strong credit quality and a disciplined capital allocation strategy.
- ATI Inc. (ATI) ↓ (BULLISH)▲
Completed a $450M 5.875% senior notes offering due 2033 with an equity clawback feature. The favorable terms (sub-6% for 7-year money) indicate strong market confidence in the aerospace/metals cycle.
- CarMax (KMX) (BULLISH)▲
Controller/PAO retiring, with CFO assuming the role without extra pay. This signals a leaner corporate structure and potential cost savings, though it concentrates accounting responsibility.
- Perrigo (PRGO) (BEARISH)▲
CEO fired for personal conduct; reaffirmed weak FY2026 guidance (Core net sales growth -3% to +1%). This creates leadership uncertainty at a time of operational decline, a classic red flag.
- GoHealth (GOCO) (BEARISH)▲
Entered prepackaged Chapter 11 with 100% lender support but existing equity holders face near-total wipeout (implied recovery minimal). The delisting from Nasdaq confirms a total loss of equity value.
- Silver Star Properties REIT ↓ (BEARISH)▲
Filed Chapter 11 with $71M+ in defaulted loans and a property posted for foreclosure. The REIT structure and real estate exposure make recovery for unsecured creditors highly unlikely.
- Pangaea Logistics (PANL) (BEARISH)▲
Three directors removed by board vote, reducing board from 10 to 7. This is an aggressive governance shake-up that could signal a strategic pivot or activist involvement, but creates near-term instability.
- SUNation Energy (SUNE) (BEARISH)▲
Reverse merger with Suniva gives pre-merger SUNE holders only 1.8% of the combined entity. The implied $2.26/share value (100% premium) is a 'Hail Mary' for existing shareholders facing near-total dilution.
- Lennar (LEN) (BULLISH)▲
Appointed two 30-year veterans as COO and EVP of Homebuilding. This strengthens operational leadership during a cyclical downturn in housing, signaling a focus on execution and cost control.
- FS KKR Capital Corp (FSK) ↓ (BULLISH)▲
Completed $900M in 7.5% unsecured notes due 2031. The high coupon reflects BDC risk, but the size and syndicate quality (BofA, JPM, KKR) show strong institutional demand for yield.
Risk Flags (10)
- GoHealth (GOCO) / Bankruptcy [HIGH RISK]▼
Prepackaged Chapter 11 with 100% lender support but equity holders get minimal recovery. Class A common stock will be delisted from Nasdaq, rendering shares nearly worthless.
- Silver Star Properties REIT / Bankruptcy↓ [HIGH RISK]▼
Filed Chapter 11 with $71M+ in defaulted loans and a promissory note maturing June 7, 2026, with property posted for foreclosure. The REIT structure limits recovery options.
- Perrigo (PRGO) / CEO Misconduct [HIGH RISK]▼
CEO Patrick Lockwood-Taylor resigned for personal conduct violations. The company reaffirmed weak FY2026 guidance (Core net sales growth -3% to +1%), indicating operational challenges alongside leadership vacuum.
- Pangaea Logistics (PANL) / Board Instability [HIGH RISK]▼
Three directors removed by board vote, reducing board size by 30%. The lack of disclosed reason and immediate effectiveness suggests significant internal conflict or a strategic disagreement.
- Cerus Corp (CERS) / Debt Load Increase↓ [HIGH RISK]▼
New $95M credit facilities increase net term debt by $5M and carry high floating rates (SOFR + 5.5% on term loan). The financial covenant (minimum TTM revenue) creates risk if revenue declines.
- Clean Energy Technologies (CETY) / Predatory Financing [HIGH RISK]▼
Subordinated loan with a make-whole premium equal to all future interest upon prepayment and a 5% default rate increase. The terms are onerous and signal desperate financing conditions.
- MetaVia (MTVA) / Reverse Split Risk [MEDIUM RISK]▼
Stockholders approved a reverse stock split (1:5 to 1:22) with 13% opposition. The wide range suggests management is preparing for a potential Nasdaq compliance fix, but the high authorized share increase signals future dilution.
- Volato Group (SOAR) / Speculative Pivot [HIGH RISK]▼
Raised only $2.2M while pivoting to AI strategy after terminating M2i Global deal. The non-binding LOIs for AI infrastructure are highly speculative, and the company faces NYSE American compliance risk.
- Twenty One Capital (XXI) / Board Instability [MEDIUM RISK]▼
SoftBank representatives stepped down after Tether's acquisition of their stake, causing an audit committee vacancy. While a new director was appointed, the rapid board turnover and Tether involvement raise governance concerns.
- Remitly Global (RELY) / Executive Departure [MEDIUM RISK]▼
CPTO Ankur Sinha resigns effective June 19, 2026, with no successor named. The departure of a key product and technology leader at a growth stage company is a material risk to execution.
Opportunities (10)
- Nurix Therapeutics (NRIX) / Roche Collaboration (OPPORTUNITY)◆
$700M upfront payment provides a multi-year cash runway with no dilution. The 50/50 US profit split on a potential best-in-class BTK degrader offers asymmetric upside. Trading at a fraction of the potential peak sales value.
- Ares Capital (ARCC) / CP Program (OPPORTUNITY)◆
The $1B commercial paper program will lower funding costs for the largest BDC, directly improving net investment income and dividend coverage. This is a structural improvement in ROE.
- Hubbell (HUBB) / NSI Electrical Acquisition (OPPORTUNITY)◆
The $1.9B debt financing for the NSI acquisition is a transformative deal in electrical infrastructure. Hubbell's ability to issue $1.9B in 7-10 year debt at 4.65%-5.15% shows strong credit market access for a strategic buyer.
- ATI Inc. (ATI) / Favorable Debt Terms↓ (OPPORTUNITY)◆
The 5.875% coupon for 7-year non-call 3 money is attractive for a cyclical industrial. The equity clawback feature (up to 35% at 105.875%) provides optionality to refinance if equity markets are favorable.
- Lennar (LEN) / Operational Deepening (OPPORTUNITY)◆
Appointing two 30-year veterans to COO and EVP roles signals a focus on operational efficiency and margin protection during a housing downturn. This is a defensive move that could lead to market share gains.
- CarMax (KMX) / Cost Efficiency (OPPORTUNITY)◆
The Controller/PAO retirement with CFO absorbing the role without extra pay is a small but positive sign of cost discipline. The 15-year CFO tenure provides stability.
- Casey's General Stores (CASY) / Board Upgrade (OPPORTUNITY)◆
Appointing Colgate-Palmolive's CFO to the board adds world-class financial and M&A expertise. This could signal a more aggressive capital allocation strategy (M&A, buybacks) for the 3rd largest c-store chain.
- Schrodinger (SDGR) / Clean Separation (OPPORTUNITY)◆
The separation agreement with the former CCO is clean and standard. The lack of non-compete or litigation risk removes an overhang, allowing the company to focus on its core software and drug discovery business.
- Savara (SVRA) / Capital Raise Capacity (OPPORTUNITY)◆
Authorizing 601M total shares (600M common) provides immense flexibility for future capital raises or strategic transactions. While dilutive in theory, it positions the company to act quickly on opportunities.
- FS KKR Capital Corp (FSK) / Yield Opportunity↓ (OPPORTUNITY)◆
The 7.5% coupon on $900M in unsecured notes offers a compelling yield for income-focused investors in a BDC with strong sponsor backing (KKR). The wide syndicate of 20+ banks ensures liquidity.
Sector Themes (6)
- Debt Market Divergence◆
Investment-grade and BDC names (Hubbell, ATI, ARCC, FSK) are accessing debt markets at favorable terms (sub-6% for IG, 7.5% for BDCs), while distressed names (CETY, Silver Star) are forced into onerous financing or bankruptcy. This 'two-tier' credit market is a key macro signal.
- Solar Manufacturing Consolidation◆
SUNation's reverse merger with Suniva highlights the severe overcapacity in US solar cell manufacturing (59 GW module assembly vs 3 GW cell capacity). The combined entity's 1 GW facility and planned 4.5 GW expansion face an uphill battle against cheap imports.
- Biotech Mega-Deal Validation◆
Nurix's $700M upfront from Roche is the largest upfront in this batch and validates the targeted protein degradation (TPD) space. This could trigger a re-rating for other TPD-focused biotechs (e.g., Arvinas, Kymera) as Big Pharma continues to pay premiums for platform technology.
- Governance Turmoil as a Leading Indicator◆
Three companies (Perrigo, Pangaea, Twenty One Capital) experienced significant governance disruptions (CEO fired, 3 directors removed, board shake-up). Historically, such events precede strategic shifts, restructurings, or M&A, making these names high-conviction watch items.
- AI Pivot Speculation◆
Volato Group's pivot to AI after raising only $2.2M and terminating a prior deal is a microcosm of the 'AI-washing' trend. Investors should be highly skeptical of small-cap companies rebranding as AI plays without a clear revenue path or technology moat.
- BDC Capital Efficiency Race◆
Ares Capital's $1B CP program and FS KKR's $900M note offering show that large BDCs are aggressively optimizing their capital structures to lower funding costs and maintain dividend yields. This creates a competitive advantage over smaller BDCs with higher cost of capital.
Watch List (8)
- Perrigo (PRGO)👁
CEO search and Q2 2026 earnings (late July). Watch for further guidance cuts or a strategic review. The interim CEO's background (food/consumer goods) may signal a portfolio divestiture. [Date: Q2 Earnings ~Late July 2026]
- SUNation Energy (SUNE)👁
Reverse merger with Suniva closing (H2 2026). Watch for SEC effectiveness of S-4 and stockholder vote. The 1.8% ownership for existing holders makes this a near-total loss event unless the combined entity succeeds. [Date: H2 2026]
- GoHealth (GOCO)👁
Chapter 11 emergence before AEP 2026. Watch for the equity recovery amount (if any) and the new ownership structure. The delisting to OTCQB will reduce liquidity to near zero. [Date: Before Oct 2026 AEP]
-
Chapter 11 proceedings and the McKinney property foreclosure (posted for June 2, 2026). Watch for asset sales or a restructuring plan. The $71M+ in defaulted loans suggests a lengthy process. [Date: Ongoing]
- Nurix Therapeutics (NRIX)👁
Roche collaboration closing and initial clinical data readouts for bexobrutideg. The $700M upfront provides a multi-year catalyst path. Watch for partnership expansions or new indications. [Date: H2 2026]
- Pangaea Logistics (PANL)👁
Board composition and strategic direction after the 3 director removals. Watch for a potential sale process, activist involvement, or a change in dividend policy. The 30% board reduction is a major governance event. [Date: Next 90 days]
-
Revenue performance relative to the new TTM minimum revenue covenant. The floating-rate debt (SOFR + 5.5%) creates earnings risk if rates stay high. Watch for Q2 2026 revenue. [Date: Q2 2026 Earnings]
- Celcuity (CELC)👁
$400M convertible note offering (due 2032). Watch for pricing terms, conversion premium, and use of proceeds (likely to fund clinical trials). The large size relative to market cap could signal aggressive pipeline expansion. [Date: June 2026]
Filing Analyses
(50)
08-06-2026
SUNation Energy, Inc. (SUNE) and Suniva have signed a definitive reverse merger agreement, under which Suniva will merge with a SUNation subsidiary and the combined company will operate under the Suniva name on Nasdaq. Pre-merger SUNation stockholders are expected to own approximately 1.8% of the combined company with an implied value of ~$2.26 per share (a ~100% premium over SUNE's last closing price), while Suniva stockholders will own ~98.2%. The transaction is targeted to close in the second half of 2026, subject to stockholder approvals, SEC effectiveness of a Form S-4, and Nasdaq listing clearance.
- · Suniva is the largest and oldest U.S. merchant manufacturer of high-efficiency monocrystalline silicon solar cells.
- · Suniva's existing 1 GW nameplate cell facility operates in Georgia; expansion of 4.5 GW in Laurens County, South Carolina is supported by expected financing targeted to close later this month (June 2026).
- · The U.S. has roughly 59 GW of solar module-assembly capacity but only about 3 GW of operational cell capacity.
- · Suniva intends to become the leading domestic solar cell supplier serving a more than 500 GW market over the next decade.
- · SUNation's largest markets include New York, Florida and Hawaii; 2025 gross margins improved into the high-30-percent range.
- · The combined company's board is expected to consist of five members, all designated by Suniva.
- · Certain key SUNation stockholders holding ~10.4% entered into voting agreements in support of the transaction.
- · The transaction is subject to risks including the One Big Beautiful Act of 2025, which has had a material negative impact on residential solar installations since January 2026.
08-06-2026
Farmer Mac announced July 1, 2026, as the effective date for Zachary N. Carpenter to assume the role of CEO, succeeding Bradford T. Nordholm, who will transition to Senior Advisor and CEO Emeritus through September 30, 2026. The leadership transition, planned since September 2025, reflects a seamless handoff and positions the company for continued mission-focused growth. Under Nordholm’s tenure, Farmer Mac doubled annual earnings and grew outstanding business volume to over $34 billion, delivering top-tier shareholder returns among S&P Financials.
- · Mr. Nordholm was appointed CEO in October 2018 and led Farmer Mac for nearly 8 years.
- · Mr. Carpenter joined Farmer Mac in May 2019 and has been instrumental in expanding support for Renewable Energy, Broadband Infrastructure, and Corporate AgFinance.
- · The transition was announced in September 2025, when Carpenter was named President and COO and designated as successor.
- · Mr. Nordholm will serve as Senior Advisor to the CEO with the honorary title of CEO Emeritus through September 30, 2026.
- · The filing includes items 5.02 (Director/Officer Departure/Election), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits).
08-06-2026
GoHealth, Inc. has initiated a voluntary prepackaged Chapter 11 bankruptcy process to restructure its balance sheet, supported by 100% of its lenders, over 60% of Class A common stockholders, and over 99% of GoHealth Holdings, LLC interest holders. The company expects to continue operations without interruption and emerge before the 2026 annual enrollment period, with ownership transitioning to certain lenders. However, the restructuring will result in the delisting of Class A common stock from Nasdaq, and existing common equity holders will receive only limited recovery, reflecting a significant loss of value for shareholders.
- · The restructuring will reinstate preferred equity of GoHealth, Inc. and provide payment in full for trade payables and other ordinary course obligations.
- · A cash payment will be provided to holders of GoHealth common equity, though the amount is not specified.
- · The company expects Class A common stock to be delisted from Nasdaq and subsequently quoted on the OTCQB Basic Market or another over-the-counter market.
- · GoHealth has filed customary motions with the Bankruptcy Court to maintain uninterrupted operations and pay vendors and suppliers in full.
- · The restructuring is expected to be completed before the start of the 2026 annual enrollment period (AEP).
08-06-2026
Ares Capital Corporation (ARCC) announced the establishment of its inaugural $1 billion commercial paper program, allowing issuance of short-term unsecured notes to reduce funding costs. The program is backstopped by the company's $5.5 billion Revolving Credit Facility, and proceeds will be used for general corporate purposes. No negative or flat metrics are present in this filing.
- · The commercial paper notes are unsecured and rank pari passu with the company's other senior unsecured indebtedness.
- · The notes will not be registered under the Securities Act of 1933 and are offered only through definitive offering documentation.
- · Ares Capital was the largest publicly traded BDC by market capitalization as of March 31, 2026.
- · The company was founded in 2004 and is externally managed by a subsidiary of Ares Management Corporation.
08-06-2026
On June 4, 2026, Jordan Krugman resigned from all positions at Invesco Capital Management LLC and its affiliates, including his role as a member of the Board of Managers, effective August 3, 2026. The Managing Owner is considering a replacement. This filing is a routine disclosure of a director/officer departure with no financial impact.
- · Resignation effective date: August 3, 2026.
- · The resignation covers all positions at the Managing Owner and its affiliates.
- · The Managing Owner is currently considering a replacement.
08-06-2026
AVITA Medical, Inc. issued a warrant to Perceptive Credit Holdings V, LP on June 5, 2026, following stockholder approval at the 2026 Annual Meeting on June 3, 2026. The warrant allows Perceptive to purchase up to 500,000 shares of common stock at $3.4019 per share, with an additional 150,000 shares vesting if the Company draws the $10 million Additional Commitment Amount under the existing $60 million credit facility. The warrant shares are registered under the Company's existing S-3 registration statement.
- · The warrant exercise price is $3.4019 per share.
- · The warrant shares are registered under Registration Statement on Form S-3 (File No. 333-294790) with a prospectus supplement filed on June 5, 2026.
- · The Additional Commitment Amount of $10 million is subject to a net revenue requirement and must be drawn by March 31, 2027.
- · The Credit Agreement was originally entered into on January 13, 2026.
08-06-2026
MSD Investment Corp. amended its Senior Secured Credit Agreement to increase the limit on Shorter Term Unsecured Indebtedness from $200,000,000 to $600,000,000, tripling the allowable amount. The amendment, effective June 5, 2026, was executed with JPMorgan Chase as administrative agent and a syndicate of lenders including Goldman Sachs, Deutsche Bank, Morgan Stanley, and others. The filing does not disclose any negative or flat performance metrics, but the increased debt capacity may signal higher leverage or growth financing needs.
- · The amendment also corrected a reference from 'HSBC Bank USA' to 'HSBC Bank USA, N.A.' in the existing credit agreement.
- · The amendment was governed by New York law and included a jury trial waiver.
- · No Default or Event of Default existed immediately prior to or after the amendment effective date, as represented by the borrower.
08-06-2026
On June 4, 2026, Jordan Krugman notified Invesco Galaxy Bitcoin ETF (BTCO) of his resignation from all positions at the Sponsor, Invesco Capital Management LLC, including his role on the Board of Managers, effective August 3, 2026. The Sponsor is currently considering a replacement. No financial impact or performance data is included in this filing.
- · Resignation effective date: August 3, 2026.
- · Filing date: June 8, 2026; event date: June 4, 2026.
- · Registrant is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
08-06-2026
On June 4, 2026, Jordan Krugman resigned from all positions at Invesco Capital Management LLC and its affiliates, including his role on the Board of Managers of the Managing Owner, effective August 3, 2026. The Managing Owner is currently considering his replacement. No financial impact or performance data is disclosed in this filing.
- · Resignation effective date: August 3, 2026
- · Filing date: June 8, 2026
- · Event date: June 4, 2026
- · The Managing Owner is actively considering a replacement for Mr. Krugman
08-06-2026
Lennar Corporation announced the appointment of Jim Parker as Chief Operating Officer and David Grove as Executive Vice President, Homebuilding, effective immediately. Both executives bring 30 years of industry experience and will continue to report to Stuart Miller, Executive Chairman, CEO and President.
- · Jim Parker joined Lennar through the 2018 merger with CalAtlantic Homes.
- · David Grove has spent his entire career with Lennar since 1999, starting as a Construction Area Manager in Austin.
- · Both executives previously served as Area Presidents leading East and West operations respectively.
- · Lennar was founded in 1954 and is one of the nation's largest homebuilders.
08-06-2026
Silver Star Properties REIT, Inc. filed for Chapter 11 bankruptcy on May 28, 2026, along with its subsidiary Silver Star Virginia Parkway, LLC. The company is the guarantor of four loan agreements currently in default, with outstanding principal amounts of $24,599,690, $15,530,000, $17,000,000, and $8,100,000. Additionally, a promissory note of $5,750,000 is in default and the related property has been posted for foreclosure.
- · The Chapter 11 cases are filed in the United States Bankruptcy Court for the Northern District of Texas under case numbers 26-42316-mxm11 (Silver Star) and 26-42315-mxm11 (McKinney Debtor).
- · The McKinney Debtor's promissory note matures on June 7, 2026, and the lender has posted the storage property for foreclosure on June 2, 2026.
- · The company issued a press release on June 5, 2026, announcing the bankruptcy filing and its strategic path forward.
08-06-2026
Volato Group announced a $2.2 million strategic investment led by Catheter Precision and other institutional investors, strengthening its balance sheet as it pivots to an AI-focused strategy. The company is evaluating two non-binding LOIs for AI infrastructure and power generation transactions, but no definitive agreements exist and the M2i Global transaction was recently terminated. While the investment provides near-term liquidity, the AI strategy remains highly speculative with no guaranteed outcomes.
- · The investment is in restricted common stock and subject to customary closing conditions, including NYSE American authorization of a supplemental listing application.
- · Volato owns Parslee, an AI software platform focused on deterministic document intelligence, and is developing Volato AI for aviation-specific AI agents.
- · The M2i Global transaction was recently terminated, but Volato believes this does not affect its NYSE American compliance plan.
- · No definitive agreements have been executed for the AI infrastructure opportunities, and there is no assurance either will result in a completed transaction.
- · Catheter Precision becomes Volato's largest shareholder as a result of this investment.
08-06-2026
Catheter Precision, Inc. (VTAK) entered into a Securities Purchase Agreement on June 7, 2026, to purchase 2,941,176 shares of Volato Group, Inc. (SOAR) at $0.34 per share for an aggregate purchase price of $1,000,000 in a private placement. As of June 5, 2026, the market value of these shares was approximately $1,000,000, and Volato also agreed to deliver freely tradeable equity securities of a third-party entity valued at approximately $1,100,000. However, the company cautioned there is no guarantee it will realize these current values through future sales.
- · The closing of the private placement is subject to customary conditions including accuracy of representations and warranties, performance of covenants, and absence of a Material Adverse Effect with respect to Volato.
- · Volato agreed to file a registration statement on Form S-3 covering resale of the shares within 10 calendar days of the Registration Rights Agreement and use best efforts to have it declared effective promptly.
- · The Registration Rights Agreement includes customary provisions for registration procedures, expenses, liquidated damages, and indemnification.
08-06-2026
SUNation Energy, Inc. entered into a securities purchase agreement on June 7, 2026, to sell 2,390,000 shares of common stock at $1.13 per share, raising gross proceeds of $2,700,700. The offering is exempt from registration under Section 4(a)(2) and Rule 506, and the company expects to close on June 9, 2026, using net proceeds for working capital and general corporate purposes. Concurrently, the company entered into a registration rights agreement and a placement agency agreement with Maxim Group LLC, which will receive a 4.5% cash fee on gross proceeds plus $45,000 in expense reimbursement.
- · The offering includes no warrants and no price adjustment features.
- · Beneficial ownership limitation set at 4.99% (or 9.99% at holder's option) with ability to increase upon 61 days' notice.
- · Placement agency agreement dated June 5, 2026, with exclusive engagement until completion of offering.
- · Company responsible for all registration expenses under the Registration Rights Agreement.
08-06-2026
Clean Energy Technologies, Inc. (CETY) entered into a subordinated business loan and security agreement on May 27, 2026, with Agile Capital Funding, LLC and Agile Lending, LLC for a term loan. The loan proceeds will be used to pay off an existing balance of $24,546.64 and fund general business requirements. The agreement includes a make-whole premium on prepayments and a default interest rate increase of 5.00%.
- · The loan is subordinated and secured by a security interest in the borrower's collateral.
- · Borrower must pay a make-whole premium equal to all interest that would have been paid through the Maturity Date upon any prepayment.
- · Interest is computed on a 360-day year basis.
- · The loan may not be reborrowed once repaid.
- · Borrower represents that there is no pending litigation involving more than $500,000.
08-06-2026
Nurix Therapeutics announced a global collaboration with Roche to co-develop and co-commercialize bexobrutideg, a potential best-in-class BTK degrader, across malignant hematology, immunology, and neurology. Nurix will receive an upfront cash payment of $700 million and is eligible for up to $2.3 billion in milestones, with profits and losses shared equally in the U.S. and royalties on ex-U.S. sales. The collaboration includes a robust clinical development plan, but Nurix faces risks from sharing 40% of development costs and the need to establish a U.S. commercialization infrastructure.
- · Development costs shared 40% Nurix, 60% Roche.
- · U.S. profits and losses split equally.
- · Nurix eligible for low- to high-teens royalties on ex-U.S. sales.
- · Bexobrutideg is an oral, brain-penetrant BTK degrader targeting wild-type and mutant BTK.
- · Phase 2 trials planned in multiple sclerosis (MS) and chronic spontaneous urticaria (CSU).
- · Goldman Sachs acted as exclusive financial advisor to Nurix.
08-06-2026
Twenty One Capital, Inc. (XXI) appointed Paul S. Lalljie as an independent director and audit committee member, restoring compliance with NYSE and SEC audit committee independence requirements after SoftBank representatives stepped down in connection with Tether International's acquisition of SoftBank's stake on May 19, 2026. The company holds over 43,500 bitcoin and aims to build a Bitcoin-native public company. While the appointment strengthens governance, the departure of SoftBank representatives and the audit committee vacancy highlight recent board instability.
- · The appointment follows the May 19, 2026 closing of Tether International's acquisition of SoftBank Group's stake in Twenty One.
- · SoftBank's representatives on the Board stepped down, including one audit committee member, causing a vacancy that triggered NYSE notification.
- · Paul Lalljie currently serves as Member of the Supervisory Board and Audit Committee Chair at Bitdefender.
- · He previously served as CEO and CFO of 2U and CFO of Neustar.
- · Twenty One's strategy includes Bitcoin treasury, financial services, mining, and capital markets for recurring revenue and long-term Bitcoin accumulation.
08-06-2026
On June 7, 2026, Pangaea Logistics Solutions Ltd. removed three directors—Eric S. Rosenfeld, David D. Sgro, and Anthony Laura—from its Board, reducing the board size from ten to seven directors. The removals were executed under the company's Bye-Laws, which allow a director to be removed upon written request by at least three-quarters of the other directors. The remaining Board believes a seven-person board will improve efficiency and decision-making, but the departure of three directors represents a significant governance change.
- · The removals were effective immediately on June 7, 2026.
- · The company's Bye-Laws (Section 24.1.7) allow removal by written request of at least three-quarters of the other directors.
- · The Board now consists of seven directors, down from ten.
- · The filing was signed by CFO Gianni Del Signore on June 8, 2026.
08-06-2026
American Vanguard Corporation (NYSE:AVD) announced the voting results from its 2026 Annual Meeting of Stockholders held on June 3, 2026. All seven director nominees were elected, and all other ballot initiatives—including ratification of Deloitte Touche, LLP as auditor, advisory vote on say-on-pay frequency, and advisory approval of executive compensation—passed with overwhelming shareholder support. No negative or dissenting metrics were disclosed, and no financial results or period-over-period comparisons were provided in this filing.
- · The annual meeting was held on June 3, 2026.
- · All seven director nominees received more votes 'for' than 'against'.
- · The company has more than 1,000 product registrations worldwide.
- · The company is headquartered in Newport Beach, CA.
- · Robert Winters of Alpha IR Group is the investor contact.
08-06-2026
On June 8, 2026, Remitly Global, Inc. disclosed that Ankur Sinha, the Chief Product and Technology Officer, resigned effective June 19, 2026. The resignation was not due to any disagreement over the company's financial reporting or accounting policies. No successor or interim replacement has been announced.
- · Resignation effective June 19, 2026.
- · No disagreement regarding financial reporting or accounting policies.
- · No successor or interim appointment announced.
08-06-2026
IGC Pharma, Inc. filed an 8-K on June 8, 2026, reporting the entry into a material agreement (Exhibit 10.1) under Items 1.01 and 2.03. The filing does not disclose specific financial terms or performance metrics, making it a procedural disclosure of a contractual obligation.
- · Filing type is 8-K (current report) dated June 8, 2026.
- · Items reported: 1.01 (Entry into Material Definitive Agreement) and 2.03 (Creation of Direct Financial Obligation).
- · The material agreement is referenced as Exhibit 10.1 but no details of the agreement are provided in the filing text.
08-06-2026
Mannatech announced the appointment of Yasir Haider as Chief Financial Officer, effective June 3, 2026. Haider had served as Interim CFO since March 20, 2026, and previously as Controller since January 2025. The filing includes forward-looking statements and contact information.
- · Yasir Haider joined Mannatech on January 6, 2025, as Controller.
- · He holds an MBA from West Texas A&M University and began his career in public accounting.
- · Mannatech operates in 25 markets, with a separate cross-border e-commerce platform in China.
08-06-2026
Truist Financial Corporation announced the appointment of Catherine Bessant to its board of directors, effective June 8, 2026. Bessant, a former Bank of America vice chair and CEO of Foundation For The Carolinas, will serve on the board's risk committee. The filing contains no financial results or period-over-period comparisons, only a governance update.
- · Catherine Bessant was inducted into American Banker's 'Most Powerful Women in Banking' Hall of Fame in 2020.
- · She most recently served as CEO of Foundation For The Carolinas, one of the largest community foundations in the U.S.
- · Bessant retired as vice chair, global strategy, and as a member of Bank of America's executive management team after a four-decade career.
- · She previously served as chief operations and technology officer at Bank of America, leading business continuity and information security strategies.
- · Bessant serves on the board of Zurich Insurance Group and is on the advisory board of the University of Michigan Ross School of Business.
- · She is the immediate past chair of the USA Field Hockey board of directors.
- · Truist had total assets of $549 billion as of March 31, 2026.
08-06-2026
Smart Sand, Inc. stockholders approved the 2026 Equity Incentive Plan (replacing the 2016 Plan) and the 2026 Employee Stock Purchase Plan at the June 2, 2026 annual meeting. The 2026 Plan authorizes up to 2.4 million new shares plus carryover from the 2016 Plan, while the ESPP reserves 3.0 million shares for employee purchases at a 15% discount. Stockholders also elected Sharon Spurlin and Timothy J. Pawlenty as Class I directors, ratified Grant Thornton LLP as auditor, and approved executive compensation on an advisory basis.
- · The 2026 Plan expires on June 1, 2036, unless terminated earlier by the Board.
- · The ESPP allows employee contributions from 1% to 20% of compensation via payroll deductions, with six-month offering periods starting January 1 and July 1.
- · The ESPP purchase price is 85% of the lower of fair market value on the enrollment date or exercise date, but not less than par value.
- · Sharon Spurlin received 24,307,260 votes for and 1,195,670 withheld; Timothy J. Pawlenty received 19,850,422 for and 5,652,508 withheld.
- · Ratification of Grant Thornton LLP passed with 32,849,141 for, 14,720 against, and 116,894 abstained.
- · Advisory vote on executive compensation: 24,346,879 for, 1,061,089 against, 94,962 abstained, 7,477,825 broker non-votes.
- · 2026 Plan approval: 20,547,767 for, 4,849,543 against, 105,620 abstained, 7,477,825 broker non-votes.
- · ESPP approval: 25,324,782 for, 86,202 against, 92,128 abstained, 7,477,825 broker non-votes.
- · The Board also approved forms of award agreements for time-vested, performance-adjusted, and combined restricted stock awards under the 2026 Plan.
08-06-2026
Mitesco, Inc. (MITI) announced the launch of its RoboAgent Test Bed Team, an initiative to gather feedback from real estate industry leaders as it develops its AI-powered productivity platform. The team includes executives from eXp Realty, Kim Hughes & Company, and The Lotierzo Group. However, the filing provides no financial data, revenue figures, or commercialization timelines, and the company remains in a development-stage phase with ongoing execution risks.
- · Mitesco trades on the OTCQB under ticker MITI.
- · The RoboAgent platform aims to integrate CRM, MLS, and transaction data into prioritized daily actions using AI.
- · The Test Bed Team will evaluate product functionality, workflows, coaching content, integrations, and user experience.
- · Brian Valania emphasized that RoboAgent is 'not about replacing agents—it’s about empowering them.'
- · The company expects Test Bed Team feedback to help refine RoboAgent ahead of broader commercialization.
- · Mitesco operates via two divisions: Centcore (data center cloud services) and Vero Technology Ventures (venture arm for productivity-driven cloud technologies).
08-06-2026
CarParts.com, Inc. appointed Tim Nauss as a Class II director on June 6, 2026, increasing the board size to seven. Mr. Nauss is independent and will receive standard non-employee director compensation including a $50,000 annual retainer.
- · Mr. Nauss will serve until the 2029 Annual Meeting of Stockholders or until earlier death, disqualification, resignation or removal.
- · No family relationships or material interests in transactions requiring disclosure under Item 404(a) of Regulation S-K.
- · Mr. Nauss will enter the Company's standard form of indemnification agreement.
08-06-2026
SI-BONE, Inc. entered into a Third Amendment to Lease on June 5, 2026, extending its lease for office space at 471 El Camino Real, Santa Clara, California by one month to August 31, 2026, with an option to further extend to September 30, 2026. The amendment keeps the premises on an 'AS-IS' basis with no landlord improvement obligations and sets monthly base rent at $43,696 ($2.00 per rentable square foot). The short-term extension suggests the company is managing its real estate footprint conservatively, likely in line with ongoing operational needs.
- · Lease term originally scheduled to expire July 31, 2026; extended to August 31, 2026 with option to extend to September 30, 2026.
- · Tenant must deliver written extension notice by August 15, 2026 to exercise the additional one-month extension.
- · No further extension rights beyond September 30, 2026.
- · Tenant represents it is not a 'qualified commercial tenant' under California law.
- · No default exists under the lease as of the amendment date.
08-06-2026
Celcuity Inc. announced a proposed underwritten public offering of $400 million aggregate principal amount of convertible senior notes due 2032, with an option for underwriters to purchase an additional $60 million. The company intends to use net proceeds to repay outstanding obligations under its loan agreement with Oxford Finance LLC and for working capital and general corporate purposes. The offering is subject to market conditions, and there is no assurance of completion.
- · The convertible notes will mature on August 1, 2032, unless earlier converted, redeemed or repurchased.
- · Interest will be payable semi-annually in arrears.
- · Upon conversion, the company may pay cash, shares of common stock, or a combination.
- · The interest rate, conversion rate, offering price and other terms are to be determined upon pricing.
- · The company has filed a registration statement and preliminary prospectus supplement with the SEC.
- · Joint book-running managers: Jefferies, J.P. Morgan, TD Cowen, Guggenheim Securities.
- · Lead manager: LifeSci Capital; Co-managers: Craig-Hallum and Wolfe | Nomura Alliance.
- · The company's lead therapeutic candidate is gedatolisib, a kinase inhibitor of the PI3K/AKT/mTOR pathway.
- · Phase 3 trial VIKTORIA-1 evaluated gedatolisib in HR+/HER2- advanced breast cancer with PIK3CA WT and MT tumors.
- · Phase 3 trial VIKTORIA-2 is ongoing for first-line treatment of HR+/HER2- advanced breast cancer.
- · Phase 1b/2 trial CELC-G-201 is evaluating gedatolisib with darolutamide in metastatic castration-resistant prostate cancer.
08-06-2026
MetaVia Inc. (MTVA) held its 2026 virtual annual meeting on June 8, 2026, where stockholders approved all five proposals, including the election of two Class I directors, ratification of BDO USA as auditor, a reverse stock split (1-for-5 to 1-for-22), an amendment to the 2022 Equity Incentive Plan increasing authorized shares by 200,000, and an adjournment proposal. The reverse stock split and equity plan amendments were approved with strong support (86.3% and 97.9% of votes cast, respectively), but the reverse split proposal also saw notable opposition (373,239 against, 13.0% of votes cast).
- · The reverse stock split proposal received 2,472,949 votes for, 373,239 against, and 20,357 abstentions, with no broker non-votes.
- · The equity plan amendment received 1,893,233 votes for, 35,799 against, 5,708 abstentions, and 931,805 broker non-votes.
- · The adjournment proposal received 1,902,616 votes for, 29,372 against, 2,752 abstentions, and 931,805 broker non-votes.
- · The ratification of BDO USA as auditor received 2,772,109 votes for, 89,718 against, and 4,718 abstentions.
- · The Class I directors were elected with over 99% of votes cast (excluding broker non-votes) in favor.
08-06-2026
On June 5, 2026, Cerus Corporation entered into two new credit facilities with MidCap Financial: a secured term loan facility of up to $65.0 million (with $35.0 million drawn at closing to refinance existing debt) and a secured revolving credit facility of up to $30.0 million (with $29.9 million drawn at closing). The agreements amend and restate Cerus's existing credit agreements from March 2023, extending the revolving line maturity to June 1, 2031. The new facilities significantly increase Cerus's debt load and include floating-rate interest (SOFR + 5.50% on the term loan, SOFR + 3.70% on the revolver) and a financial covenant requiring trailing twelve-month minimum net revenue, which could strain the company if revenue declines.
- · Cerus repaid $30.0 million of existing term loans on the closing date but drew $35.0 million in new term loan proceeds, increasing net term debt by $5.0 million.
- · The revolving credit facility matures June 1, 2031; interest is paid monthly; loans can be borrowed, repaid, and re-borrowed.
- · An Additional Tranche of up to $30.0 million under the term loan facility is available in increments of $5.0 million, subject to lender approval.
- · The company must pay an exit fee (percentage of amount borrowed) upon final payment of the term loan, and a pro rata portion on any prepayment.
- · Revolving facility includes an unused line fee based on average daily unused allowable borrowing base, a collateral management fee, and a minimum drawn balance requirement.
- · Covenant requires trailing twelve-month minimum net revenue, tested quarterly.
- · Prepayment of term loans is not subject to an early termination fee after the first year from closing (June 5, 2027).
- · Termination fee on revolving facility also waived after the first year from closing.
- · All obligations are secured by substantially all assets (with exclusions).
- · Cross-default provisions include certain material contracts and indebtedness; a material adverse change clause is an event of default.
- · The new term loan borrows $35.0M vs. $30.0M repaid, indicating the company increased total drawn term debt by $5.0M at closing.
08-06-2026
Plexus Corp. entered into a Second Amended and Restated Credit Agreement dated June 5, 2026, amending and restating its existing credit facility with JPMorgan Chase Bank, N.A. as Administrative Agent, and including PNC Bank, U.S. Bank, Bank of America, and HSBC as co-agents and joint lead arrangers. The agreement extends the maturity date of the revolving credit facility, re-evidences outstanding obligations, and sets forth terms for loans and other financial accommodations. No specific financial amounts or changes in commitment size are disclosed in the filing.
- · The agreement amends and restates the prior Amended and Restated Credit Agreement dated June 9, 2022.
- · The agreement includes provisions for swing line loans, facility letters of credit, and an increase option for commitments.
- · Financial covenants are outlined in Section 6.18, including an Adjusted Covenant Period mechanism.
- · The agreement covers multiple currencies (Dollars, Euros, Pounds Sterling) with benchmark rates including Adjusted Term SOFR Rate, Adjusted EURIBOR Rate, and Adjusted Daily Simple RFR.
- · The agreement includes a cross-guarantee structure among the company and subsidiary borrowers.
08-06-2026
Avalo Therapeutics held its 2026 Annual Meeting on June 2, 2026, with approximately 85% of outstanding shares represented. Stockholders elected seven directors to the Board and ratified Ernst & Young LLP as the independent auditor for fiscal year 2026. However, the approval of the Second Amended and Restated 2016 Employee Stock Purchase Plan (A&R 2016 ESPP) was narrowly passed with 14,513,683 votes for and 6,588,576 against, indicating significant shareholder opposition.
- · The A&R 2016 ESPP was approved with 14,513,683 votes for, 6,588,576 against, and 343 abstentions, plus 1,569,682 broker non-votes.
- · Ratification of Ernst & Young LLP as independent auditor passed overwhelmingly: 22,513,332 for, 153,320 against, 5,632 abstentions.
- · All seven director nominees were elected with strong support; the lowest vote total was Aaron Kantoff with 21,078,660 for and 23,942 withheld.
- · The Board adopted the A&R 2016 ESPP on April 2, 2026, prior to shareholder approval.
08-06-2026
Savara Inc. filed an 8-K on June 8, 2026, announcing a certificate of amendment to its Amended and Restated Certificate of Incorporation, effective June 4, 2026. The amendment increases the authorized share count from a prior amount (not specified) to 601 million shares (600 million common, 1 million preferred), with a par value of $0.001 per share. While this provides capacity for future capital raises, the filing does not disclose any specific immediate use of the new shares, and the company has not reported corresponding financial results or guidance.
- · The amendment was approved by the board and stockholders in accordance with Section 242 of the Delaware General Corporation Law.
- · Prior amendments to the certificate were filed on June 4, 2018, June 10, 2021, and June 6, 2024.
- · The original certificate was filed under the name Victoria Enterprises on December 1, 1995.
08-06-2026
ATI Inc. completed a $450M offering of 5.875% Senior Notes due 2033 via an underwriting agreement with Goldman Sachs & Co. LLC. The notes mature June 15, 2033, with semiannual interest payments starting December 15, 2026, and include call provisions (make-whole premium before June 2029, par-plus thereafter) and an equity clawback feature allowing redemption of up to 35% at 105.875% using equity offering proceeds. No prior-period or operational financial data is included in this 8-K, so no period-over-period comparisons are available.
- · The Notes were issued under a shelf registration statement and governed by the base Indenture from Sept 2021, as supplemented by the Third Supplemental Indenture dated June 8, 2026.
- · Interest on the Notes is payable semi-annually on June 15 and December 15, commencing December 15, 2026.
- · Before June 15, 2029, ATI may redeem the Notes at a make-whole premium (100% of principal plus applicable premium); on or after June 15, 2029, at specified redemption prices set in the Supplemental Indenture, plus accrued interest.
- · An equity clawback feature permits ATI to redeem up to 35% of the Notes at 105.875% of principal using net proceeds from qualified equity offerings, provided at least 65% of the original principal remains outstanding after each such redemption.
- · The Underwriting Agreement was executed on June 3, 2026, with Goldman Sachs & Co. LLC as representative of the underwriters.
- · ATI has agreed to indemnify the underwriters against certain liabilities, including Securities Act liabilities.
08-06-2026
Hubbell Incorporated priced a $1.9 billion senior notes offering on June 2, 2026, consisting of three tranches: $500 million of 4.650% notes due 2031, $700 million of 4.900% notes due 2033, and $700 million of 5.150% notes due 2036. The net proceeds, together with cash on hand and/or additional borrowings, will be used to finance the proposed acquisition of NSI Electrical Buyer, Inc., repay certain NSI indebtedness, and pay related transaction costs. The offering is expected to close on June 8, 2026, and the company reported 2025 revenues of $5.8 billion.
- · The offering is being made under an effective shelf registration statement on Form S-3.
- · Joint book-running managers are J.P. Morgan Securities LLC, BofA Securities, Inc., and HSBC Securities (USA) Inc.
- · The company's corporate headquarters is located in Shelton, CT.
- · The filing includes extensive forward-looking statements and risk factors related to trade tariffs, inflation, supply chain disruptions, and the proposed acquisition.
08-06-2026
CarMax announced the retirement of Jill Livesay, Vice President, Controller and Principal Accounting Officer, effective July 31, 2026. Enrique N. Mayor-Mora, the current Executive Vice President and CFO, will assume the role of Principal Accounting Officer upon her retirement without any additional compensation. The retirement is not due to any disagreement with the company.
- · Jill Livesay's retirement is effective as of the close of business on July 31, 2026.
- · Enrique N. Mayor-Mora has been with CarMax for 15 years, joining in 2011 as Vice President, Finance.
- · Mr. Mayor-Mora previously served as Vice President of Financial Planning and Analysis and Investor Relations at Denny's Corporation (2005-2011) and held financial roles at Gap, Inc. (2001-2005).
- · No adjustment to compensation or additional compensation will be provided to Mr. Mayor-Mora for assuming PAO duties.
- · No family relationships or material interests in transactions requiring disclosure exist for Mr. Mayor-Mora.
08-06-2026
Casey's General Stores (NASDAQ: CASY) appointed Stanley J. Sutula III, CFO of Colgate-Palmolive, to its Board of Directors, effective immediately, bringing over 35 years of corporate finance and strategic experience. The addition temporarily expands the board from 11 to 12 directors, as director Cara Heiden announced her retirement effective September 2, 2026 after nearly a decade of service. The board change is neutral operationally but adds financial expertise to oversee strategy and risk management.
- · Sutula has served as CFO of Colgate-Palmolive since 2020, overseeing global finance, IT, and M&A.
- · Cara Heiden will retire from the Board on September 2, 2026, after nearly a decade of service including Audit Committee leadership.
- · Casey's is the third-largest convenience store retailer and fifth-largest pizza chain in the United States.
08-06-2026
On June 5, 2026, Schrödinger, Inc. entered into a separation agreement with Mannix Aklian, its former Chief Commercial Officer and Global Head of Software Sales and Marketing, confirming the terms of his previously disclosed departure. The agreement provides salary continuation for nine months, COBRA premium payments for 12 months, and total bonus payments of $88,096 (comprising quarterly and prorated annual bonuses for 2026), along with acceleration of a restricted stock unit award scheduled for July 2026. No negative or flat financial metrics are reported; the filing solely addresses executive separation terms.
- · Separation agreement signed June 5, 2026, following Mr. Aklian’s previously disclosed departure.
- · Mr. Aklian’s receipt of payments is conditioned on not revoking the agreement within 7 days, compliance with obligations, and non-disclosure/non-disparagement commitments.
- · Confidentiality, inventions, and non-solicitation provisions from the employment agreement remain in effect.
08-06-2026
Perrigo announced the resignation of President and CEO Patrick Lockwood-Taylor due to personal conduct inconsistent with the company's Code of Conduct, effective immediately. The Board appointed Albert A. Manzone, a director since 2022, as Interim President and CEO and initiated a search for a permanent successor. The company reaffirmed its full-year 2026 outlook, which includes projected All In net sales growth of (5.5)% to (1.5)% and Core net sales growth of (3.0)% to +1.0%, indicating a mixed performance outlook with expected declines in the base case.
- · Patrick Lockwood-Taylor's resignation was due to personal conduct inconsistent with the Code of Conduct, not related to business, strategy, operations, or financial reporting.
- · Albert Manzone has served on Perrigo's Board since 2022 and brings over 30 years of global leadership experience.
- · Manzone previously served as Deputy CEO of Monte-Carlo Société des Bains de Mer and CEO of Whole Earth Brands.
- · The Board reaffirmed full-year 2026 guidance originally issued on May 6, 2026.
- · All In net sales growth guidance range is (5.5)% to (1.5)%, indicating an expected decline.
- · Core net sales growth guidance range is (3.0)% to +1.0%, allowing for a potential slight increase but with a decline as the base case.
08-06-2026
Liftoff Mobile, Inc. filed an 8-K announcing the adoption of an Amended and Restated Certificate of Incorporation, effective upon filing. The amendment reclassifies each share of Class A and Class B common stock into 1.3 shares of a single class of Common Stock, eliminates fractional shares via cash payments, and authorizes 7 billion shares of Common Stock and 700 million shares of Preferred Stock. The filing also establishes board composition and vacancy-filling rights tied to Blackstone's designation rights, but no financial results or operational metrics are disclosed.
- · The reclassification converts each share of Class A and Class B common stock into 1.3 shares of Common Stock, with fractional shares settled in cash.
- · The Board is authorized to issue Preferred Stock in series with varying rights without stockholder approval.
- · Board vacancies and newly created directorships are filled by a majority of remaining directors, except when Blackstone has designation rights, in which case the Designating Stockholder fills vacancies.
- · Directors may be removed with or without cause by a majority vote of outstanding shares when Blackstone has designation rights.
08-06-2026
Palladyne AI Corp. held its 2026 annual meeting on June 8, 2026, with 69% of shares represented. Stockholders approved an amendment to the 2021 Equity Incentive Plan to increase authorized shares by 4,500,000, and also approved restricted stock unit awards covering 5,360,659 shares to senior executives. However, the amendment to the 2021 Plan received only 16,236,339 votes in favor against 6,865,822 against, indicating notable opposition.
- · Dennis Weibling was elected as Class II director with 19,383,890 votes for and 3,856,640 withheld.
- · Ratification of KPMG LLP as independent auditor for FY2026 was approved with 29,069,119 for, 3,677,340 against, and 69,794 abstentions.
- · The 2021 Plan amendment received 16,236,339 for, 6,865,822 against, and 138,369 abstentions, with 9,575,723 broker non-votes.
- · The Senior Executive Awards received 19,630,273 for, 3,440,470 against, and 169,787 abstentions, with 9,575,723 broker non-votes.
- · The Senior Executive Awards were issued under Section 4(a)(2) of the Securities Act as an unregistered sale of equity securities.
08-06-2026
At the 2026 Annual Meeting held on June 4, 2026, stockholders of Ameresco, Inc. approved an amendment to the 2020 Equity Incentive Plan, increasing the share reserve by 3,200,000 shares of Class A common stock. Additionally, Claire Hughes Johnson and Frank V. Wisneski were elected as Class I directors for three-year terms, the appointment of RSM US LLP as independent auditor was ratified, and executive compensation received non-binding advisory approval. All proposals passed with strong support; however, the equity plan amendment received roughly 12.6 million votes against and 4.6 million broker non-votes, and director Frank V. Wisneski faced the highest number of withheld votes (about 15.5 million).
- · The Plan Amendment had been approved by the Board on February 10, 2026, subject to stockholder approval.
- · Frank V. Wisneski was the only director nominee with more than 15 million votes withheld.
- · The advisory vote on executive compensation had 6,660,508 votes against and 28,587 abstentions.
- · Broker non-votes were 4,608,628 in all four proposals where applicable.
- · RSM US LLP ratification received overwhelming support, with over 121 million votes for and only 368,099 against.
- · Holders of Class A common stock are entitled to 1 vote per share, while Class B holders get 5 votes per share.
08-06-2026
DaVita Inc. entered into a Ninth Amendment to its Credit Agreement, establishing $500M in new incremental Tranche B-2 Term Loans (2026 Incremental Tranche B-2 Term Loans). The amendment modifies the existing 2019 credit facility, with the loans constituting a single class with prior Tranche B-2 Term Loans. This increases DaVita’s total debt capacity, but there are no specific metrics showing declining performance or flat growth mentioned.
- · The amendment modifies the Credit Agreement dated August 12, 2019.
- · Initial Interest Period for the new loans begins on the Ninth Amendment Effective Date (June 8, 2026) and ends on June 30, 2026.
- · Conditions for effectiveness include receipt of legal opinions, solvency certificate, secretary’s certificate, and borrower representations and warranties being true.
08-06-2026
NCR Voyix Corporation held its 2026 Annual Meeting on June 3, 2026, where stockholders approved the 2026 Stock Incentive Plan and elected eight directors. All four proposals passed, including the advisory vote on executive compensation and ratification of PricewaterhouseCoopers LLP as auditor. However, the 2026 Stock Incentive Plan received the lowest support among proposals, with 4,818,684 votes against and 132,710 abstentions, indicating some shareholder dissent.
- · The 2026 Stock Incentive Plan was approved with 122,928,557 votes for, 4,818,684 against, and 132,710 abstentions, plus 13,011,915 broker non-votes.
- · Say on Pay advisory vote passed with 126,141,264 for, 1,601,778 against, and 136,909 abstentions.
- · Ratification of PricewaterhouseCoopers LLP as auditor received 139,467,622 votes for, 1,357,399 against, and 66,845 abstentions, with no broker non-votes.
- · Laura Sen received the highest number of votes against among director nominees (4,797,076), while Janet Haugen had the fewest (759,286).
- · The Plan replaces the NCR Corporation 2017 Stock Incentive Plan, effective June 3, 2026.
08-06-2026
FedEx Corp. announced the election of Mark A. Edmunds, retired vice chairman and senior partner of Deloitte, to its Board of Directors. Mr. Edmunds will serve as Chair of the Audit and Finance Committee and as a member of the Cyber and Technology Oversight Committee. The filing contains no financial results or period-over-period comparisons.
- · Mr. Edmunds previously served as a director for Chesapeake Energy from 2018 to 2021.
- · He is currently a member of Westrock Coffee’s board of directors.
- · His primary industry focus was energy, utilities, and renewables.
- · FedEx aims to achieve carbon-neutral operations by 2040.
08-06-2026
FS KKR Capital Corp. (NYSE: FSK) completed a public offering of $900 million in 7.500% unsecured notes due 2031, with net proceeds intended for general corporate purposes, including potentially repaying outstanding debt. The offering was led by joint book-running managers including BofA Securities, J.P. Morgan, and KKR Capital Markets, among others. FSK, a leading BDC focused on middle-market U.S. companies, is advised by FS/KKR Advisor, a partnership between Future Standard (over $94 billion AUM) and KKR.
- · BofA Securities, BMO Capital Markets, J.P. Morgan, KKR Capital Markets, RBC Capital Markets and SMBC Nikko acted as joint book-running managers.
- · HSBC, ING, Mizuho, MUFG, TD Securities, Truist, Barclays, BNP Paribas, CIBC, Citigroup, Goldman Sachs, Morgan Stanley, SG Americas, UBS and Standard Chartered acted as joint lead managers.
- · ICBC Standard Bank, Keefe Bruyette & Woods, Lucid Capital Markets, R. Seelaus & Co., and U.S. Bancorp Investments acted as co-managers.
- · Filing type is 8-K with items 1.01 (entry into material definitive agreement), 2.03 (creation of direct financial obligation), 7.01 (regulation FD disclosure) and 9.01 (financial statements and exhibits).
- · Future Standard's AUM of $94 billion is estimated as of March 31, 2026 and includes investments, uncalled commitments, CLOs, JV assets and other managed assets.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Material Events SEC 8-K Filings
🇺🇸 More from United States
View all →June 09, 2026
US Pre-Market SEC Filings Roundup — June 09, 2026
US Pre-Market SEC Filings Roundup
June 09, 2026
US SEC Trading Suspension Halt Orders — June 09, 2026
US SEC Trading Suspension Halt Orders
June 09, 2026
US Earnings Financial Results SEC Filings — June 09, 2026
US Earnings Financial Results SEC Filings
June 09, 2026
Global High-Priority Regulatory Events — June 09, 2026
Global High-Priority Regulatory Events